by Team PCM | Mar 28, 2024 | Newsletter
NEW BLOG The Impact of Biosimilars and Generic Alternatives on Specialty Management As healthcare plans adapt to the evolving landscape, they are implementing strategies to effectively manage biosimilars and generic alternatives, thereby benefiting patients and...
by Team PCM | Feb 29, 2024 | Newsletter
NEW BLOG Contract and Claim Analysis: Helping Fiduciaries Manage Plan Assets Appropriately At the most basic level, many benefits experts claim to meet fiduciary duties by comparing a plan’s pharmacy contract to a handful of similar programs. A more thorough contract...
by Team PCM | Jan 25, 2024 | Newsletter
NEW BLOG 2024 Will See Higher than Normal Employer Health Cost Increases – What Actions Can You Take to Control Costs? The numbers change, but the one thing that remains constant is that health costs increase every year. Read more. INDUSTRY NEWS FDA says Florida can...
by Team PCM | Dec 21, 2023 | Newsletter
Happy Holidays, From day one, our mission has been to provide our partners with the information and support they need to make highly informed plan decisions. In the new year, we anticipate releasing exciting new features on our analytics platform and several...
by Team PCM | Nov 29, 2023 | Newsletter
NEW BLOG “Biosimilars have been proven as safe and effective as the originator biologic and are offered at a reduced price,” explains Dr. Merritt, “However, demand for the product has been slow to shift from the original biologic, especially when...
by Team PCM | Oct 30, 2023 | Newsletter
NEW BLOG Drug Rebates: Impact on Self-Insured Employer Plans Drug rebates don’t just impact spend; they apply to several aspects of the pharmacy plan. Read More. INDUSTRY NEWS Americans spend the most money for healthcare on Earth. Hospitals charge two times...
